Core B Cellular Core

Information

  • Research Project
  • 10240539
  • ApplicationId
    10240539
  • Core Project Number
    P01AI150471
  • Full Project Number
    5P01AI150471-25
  • Serial Number
    150471
  • FOA Number
    PAR-16-433
  • Sub Project Id
    8112
  • Project Start Date
    8/1/1997 - 28 years ago
  • Project End Date
    8/31/2023 - 2 years ago
  • Program Officer Name
  • Budget Start Date
    9/1/2021 - 4 years ago
  • Budget End Date
    8/31/2022 - 3 years ago
  • Fiscal Year
    2021
  • Support Year
    25
  • Suffix
  • Award Notice Date
    8/17/2021 - 4 years ago
Organizations

Core B Cellular Core

Core B Project Summary: The Goal of the Cellular Core (Core B) is to provide innovation and support to this Program Project to investigate HIV-1 Env antagonism in the context of the conformational states sampled by native HIV-1 Env. Core B will evaluate the impact of the small-molecule antagonists on sensitizing HIV-1-infected cells to antibody-dependent cellular cytotoxicity (ADCC). Core B will also help delineate the mechanisms of action of small-molecule Env inhibitors on trimeric Env expressed at the cell surface. Specifically, Core B will: (a) evaluate the ability of small- molecule Env entry inhibitors for their ability to sensitize HIV-1-infected cells to ADCC and (b) assess their impact on the conformation of functional Env trimers expressed on cell surfaces. Despite not being officially part of the Program Project in the most recent grant period, the Finzi laboratory has been a long-term collaborator and successfully interacted with Virology (Sodroski), Cyclic Peptides and Peptidomimetics (Chaiken), Small Molecule Synthesis (Smith), and Single Molecule FRET (Mothes) Projects to advance the understanding of Env conformational changes at the surface of infected cells, understand how Env conformations are modulated by different small-molecule antagonists generated by the Program Project and assess their impact on Env recognition and ADCC responses mediated by anti-Env antibodies and HIV+ sera.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    P01
  • Administering IC
    AI
  • Application Type
    5
  • Direct Cost Amount
    99646
  • Indirect Cost Amount
    0
  • Total Cost
  • Sub Project Total Cost
    99646
  • ARRA Funded
    False
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
    NIAID:99646\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    DREXEL UNIVERSITY
  • Organization Department
  • Organization DUNS
    002604817
  • Organization City
    PHILADELPHIA
  • Organization State
    PA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    191021119
  • Organization District
    UNITED STATES